Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

ClinicalTrials.gov ID: NCT03835975

Public ClinicalTrials.gov record NCT03835975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS ≥65 YEARS OF AGE WITH PRIOR PNEUMOCOCCAL VACCINATION

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 will describe the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine formulation in adults 65 years of age or older with prior pneumococcal vaccination

Study identification

NCT ID
NCT03835975
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
875 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2019 (Actual)
Primary completion
Feb 12, 2020 (Actual)
Completion
Feb 12, 2020 (Actual)
Last update posted
Feb 21, 2021

2019 – 2020

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
29
Facility City State ZIP Site status
Coastal Clinical Research, Inc. Mobile Alabama 36608 —
East Valley Gastroenterology and Hepatology Associates Chandler Arizona 85224 —
The Pain Center of Arizona Peoria Arizona 85381 —
HOPE Research Institute Phoenix Arizona 85018 —
The Pain Center of Arizona Phoenix Arizona 85018 —
Anaheim Clinical Trials, LLC Anaheim California 92801 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Clinical Research Consulting, LLC Milford Connecticut 06460 —
Optimal Research, LLC Melbourne Florida 32934 —
Synexus Clinical Research US, Inc The Villages Florida 32162 —
Meridian Clinical Research, LLC Savannah Georgia 31406 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Heartland Research Associates, LLC Wichita Kansas 67205 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
MedPharmics, LLC Metairie Louisiana 70006 —
Meridian Clinical Research, LLC Rockville Maryland 20854 —
Meridian Clinical Research, LLC Norfolk Nebraska 68701 —
MedPharmics, LLC Albuquerque New Mexico 87102 —
Carolina Institute for Clinical Research Fayetteville North Carolina 28304 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Sterling Research Group, Ltd. Cincinnati Ohio 45246 —
Prestige Clinical Research Franklin Ohio 45005 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Kaiser Permanente Center For Health Research Portland Oregon 97227 —
Columbia Research Group, Inc. Portland Oregon 97239 —
Medical Research South, LLC Goose Creek South Carolina 29445 —
Ventavia Research Group Keller Texas 76248 —
J. Lewis Research Inc. / Foothill Family Clinic Draper Draper Utah 84020 —
J. Lewis Research, Inc. - Foothill Family Clinic Salt Lake City Utah 84109 —
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121 —
J. Lewis Research, Inc. / Jordan River Family Medicine South Jordan Utah 84095 —
Kaiser Permanente Washington Health Research Institute Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03835975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 21, 2021 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03835975 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →